A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer
Clinical trial NCT03300921 · TERMINATED
Trial details
- NCT number
- NCT03300921
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2020-08-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.